ALLERGAN USA, INC. for ALLERGAN USA, INC.
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Advocacy of Allergans Social Contract with Patients to encourage greater access to critical innovative medicines. Support for strategic, market-based international trade policies to improve patient access and intellectual property protections of life-saving medical therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M HARDER | Legislative Director - Congressman Mike Bishop; Legislative Assistant - Congressman Mike Bishop; Staff Assistant/Clerk - House Committee on Ways and Means. |
| ROBERT W. LIVELY | — |
Taxation/Internal Revenue Code TAX
Potential modifications and technical corrections to the Tax Cuts and Jobs Act of 2017 (P.L. 115-97). Proposals encouraging investments into research and development of novel treatments for diseases to improve the quality of life for patients.
Foreign entity interest: Allergan plc, as the indirect parent of Allergan USA, Inc., has an interest to the extent that policy affects the tax treatment of its subsidiaries, foreign and domestic.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT W. LIVELY | — |
Copyright/Patent/Trademark CPT
Proposals to maintain and strengthen intellectual property protections to incentivize research and development of novel, new life-saving therapies to meet unmet medical needs. Proposals to modify the Hatch Waxman Act and the America Invents Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M HARDER | Legislative Director - Congressman Mike Bishop; Legislative Assistant - Congressman Mike Bishop; Staff Assistant/Clerk - House Committee on Ways and Means. |
| ROBERT W. LIVELY | — |
Health Issues HCR
Support for proposals improving access and coverage of appropriate mental health care treatment for all patients in need. Proposals encouraging investments into research and development of novel treatments for diseases to improve the quality of life for patients. Supporting protections for patients from illegal and inappropriate exposure to counterfeit and diverted medicines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M HARDER | Legislative Director - Congressman Mike Bishop; Legislative Assistant - Congressman Mike Bishop; Staff Assistant/Clerk - House Committee on Ways and Means. |
| ROBERT W. LIVELY | — |
Budget/Appropriations BUD
Proposals affecting access, coverage and reimbursements of prescription medicines and medical devices within the Medicare and Medicaid programs. Supporting adequate resources for the Food and Drug Administration to fulfill its mission. Supporting proposals to strengthen the safety and integrity of the pharmaceutical supply chain. Supporting proposals to strengthen safety standards and enforcement of the Drug Quality and Security Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M HARDER | Legislative Director - Congressman Mike Bishop; Legislative Assistant - Congressman Mike Bishop; Staff Assistant/Clerk - House Committee on Ways and Means. |
| ROBERT W. LIVELY | — |
Medicare/Medicaid MMM
Proposals affecting access, coverage and reimbursements of prescription medicines and medical devices within the Medicare and Medicaid programs. Proposals improving reimbursements for anti-microbial medications to incentivize research and development of novel therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M HARDER | Legislative Director - Congressman Mike Bishop; Legislative Assistant - Congressman Mike Bishop; Staff Assistant/Clerk - House Committee on Ways and Means. |
| ROBERT W. LIVELY | — |
Medical/Disease Research/Clinical Labs MED
Supporting proposals to maintain the highest standards of drug and medical device safety and efficacy at all appropriate regulatory agencies. Supporting medically-appropriate, scientific-based standards for bioequivalence of non-biologic complex drugs. Supporting protections for patients from illegal and inappropriate exposure to counterfeit and diverted medicines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M HARDER | Legislative Director - Congressman Mike Bishop; Legislative Assistant - Congressman Mike Bishop; Staff Assistant/Clerk - House Committee on Ways and Means. |
| ROBERT W. LIVELY | — |
Pharmacy PHA
Supporting proposals to strengthen the safety and integrity of the pharmaceutical supply chain. Supporting proposals to strengthen safety standards and enforcement of the Drug Quality and Security Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL M HARDER | Legislative Director - Congressman Mike Bishop; Legislative Assistant - Congressman Mike Bishop; Staff Assistant/Clerk - House Committee on Ways and Means. |
| ROBERT W. LIVELY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.